Its primary mode of action is to induce insulin secretion by pancreatic β-cells [18,19] and as a result, it is ineffective, when administered alone, in the treatment of insulin dependent diabetes (Type I diabetes) [20]. The gene discussed is INS; the disease is type 1 diabetes mellitus.